Watts J, Minden M, Bachiashvili K, Brunner A, Abedin S, Crossman T
Ther Adv Hematol. 2024; 15:20406207241275376.
PMID: 39290981
PMC: 11406655.
DOI: 10.1177/20406207241275376.
Song B, Yang P, Zhang S
Cancer Commun (Lond). 2024; 44(3):297-360.
PMID: 38311377
PMC: 10958678.
DOI: 10.1002/cac2.12520.
Ali W, Xiao W, Hoang H, Cali V, Kajdacsy-Balla A
Curr Issues Mol Biol. 2023; 45(12):9422-9430.
PMID: 38132437
PMC: 10742294.
DOI: 10.3390/cimb45120591.
Mongia P, Toyofuku N, Pan Z, Xu R, Kinoshita Y, Oki K
Commun Biol. 2023; 6(1):551.
PMID: 37237082
PMC: 10219947.
DOI: 10.1038/s42003-023-04925-9.
Che Y, Liu Y, Yao Y, Hill H, Li Y, Cai Q
Blood Cancer J. 2023; 13(1):27.
PMID: 36797243
PMC: 9935633.
DOI: 10.1038/s41408-023-00799-6.
Rab37 Promotes Endothelial Differentiation and Accelerates ADSC-Mediated Diabetic Wound Healing through Regulating Secretion of Hsp90α and TIMP1.
Huang H, Liang L, Sun D, Li J, Wang W, Zha L
Stem Cell Rev Rep. 2023; 19(4):1019-1033.
PMID: 36627432
DOI: 10.1007/s12015-022-10491-0.
Preventing Neurodegeneration by Controlling Oxidative Stress: The Role of OXR1.
Volkert M, Crowley D
Front Neurosci. 2021; 14:611904.
PMID: 33384581
PMC: 7770112.
DOI: 10.3389/fnins.2020.611904.
Targeting methyltransferase PRMT5 retards the carcinogenesis and metastasis of HNSCC via epigenetically inhibiting Twist1 transcription.
Fan Z, He L, Li M, Cao R, Deng M, Ping F
Neoplasia. 2020; 22(11):617-629.
PMID: 33045527
PMC: 7557877.
DOI: 10.1016/j.neo.2020.09.004.
Regulating tumor suppressor genes: post-translational modifications.
Chen L, Liu S, Tao Y
Signal Transduct Target Ther. 2020; 5(1):90.
PMID: 32532965
PMC: 7293209.
DOI: 10.1038/s41392-020-0196-9.
PRMT5-TRIM21 interaction regulates the senescence of osteosarcoma cells by targeting the TXNIP/p21 axis.
Li Y, Tong K, Lu J, Lin J, Li Z, Sang Y
Aging (Albany NY). 2020; 12(3):2507-2529.
PMID: 32023548
PMC: 7041745.
DOI: 10.18632/aging.102760.
New drugs for new targets in lymphoma.
Younes A
Hematol Oncol. 2019; 37 Suppl 1:105-109.
PMID: 31187529
PMC: 6570411.
DOI: 10.1002/hon.2592.
The Cellular p53 Inhibitor MDM2 and the Growth Factor Receptor FLT3 as Biomarkers for Treatment Responses to the MDM2-Inhibitor Idasanutlin and the MEK1 Inhibitor Cobimetinib in Acute Myeloid Leukemia.
Seipel K, Marques M, Sidler C, Mueller B, Pabst T
Cancers (Basel). 2018; 10(6).
PMID: 29857559
PMC: 6025168.
DOI: 10.3390/cancers10060170.
The Role of JMY in p53 Regulation.
Adighibe O, Pezzella F
Cancers (Basel). 2018; 10(6).
PMID: 29857553
PMC: 6025294.
DOI: 10.3390/cancers10060173.
Protein arginine methyltransferase 5 regulates multiple signaling pathways to promote lung cancer cell proliferation.
Sheng X, Wang Z
BMC Cancer. 2016; 16:567.
PMID: 27480244
PMC: 4970276.
DOI: 10.1186/s12885-016-2632-3.
Lysine methylation of promoter-bound transcription factors and relevance to cancer.
Stark G, Wang Y, Lu T
Cell Res. 2010; 21(3):375-80.
PMID: 21151202
PMC: 3193425.
DOI: 10.1038/cr.2010.174.
Restoration of DNA-binding and growth-suppressive activity of mutant forms of p53 via a PCAF-mediated acetylation pathway.
Perez R, Knights C, Sahu G, Catania J, Kolukula V, Stoler D
J Cell Physiol. 2010; 225(2):394-405.
PMID: 20589832
PMC: 3614009.
DOI: 10.1002/jcp.22285.